These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10329821)
1. Long-term immunologic effects of thymectomy in patients with myasthenia gravis. Gerli R; Paganelli R; Cossarizza A; Muscat C; Piccolo G; Barbieri D; Mariotti S; Monti D; Bistoni O; Raiola E; Venanzi FM; Bertotto A; Franceschi C J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):865-72. PubMed ID: 10329821 [TBL] [Abstract][Full Text] [Related]
2. Thymectomy and systemic lupus erythematosus (SLE). Panarese A; D'Andrea V; Pironi D; Filippini A Ann Ital Chir; 2014; 85(6):617-8. PubMed ID: 25919914 [TBL] [Abstract][Full Text] [Related]
3. [Effects of thymectomy and glucocorticoid therapy on peripheral lymphocytes in myasthenia gravis]. Huang Y; Xu X; Lin J Zhonghua Nei Ke Za Zhi; 1995 Aug; 34(8):514-7. PubMed ID: 8697907 [TBL] [Abstract][Full Text] [Related]
4. Risk of incident autoimmune diseases in patients with thymectomy. Lin TM; Chang YS; Hou TY; Hsu HC; Lin SH; Chen WS; Kuo PI; Lin YC; Chen JH; Chang CC Ann Clin Transl Neurol; 2020 Jul; 7(7):1072-1082. PubMed ID: 32478484 [TBL] [Abstract][Full Text] [Related]
5. Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis. Sempowski G; Thomasch J; Gooding M; Hale L; Edwards L; Ciafaloni E; Sanders D; Massey J; Douek D; Koup R; Haynes B J Immunol; 2001 Feb; 166(4):2808-17. PubMed ID: 11160348 [TBL] [Abstract][Full Text] [Related]
6. Shifting of the blood T:B lymphocyte ratio in myasthenia gravis patients after thymectomy. Russo L; Scoppetta C; Tonali P Neurology; 1977 Jul; 27(7):642-5. PubMed ID: 301616 [TBL] [Abstract][Full Text] [Related]
7. Mixed connective tissue disease after thymectomy in refractory myasthenia gravis. Kobza A; Keenan M; Ivory C Rheumatol Int; 2022 Nov; 42(11):2077-2084. PubMed ID: 34432146 [TBL] [Abstract][Full Text] [Related]
8. Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis. Melms A; Malcherek G; Gern U; Sommer N; Weissert R; Wiethölter H; Bühring HJ J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):46-51. PubMed ID: 8094093 [TBL] [Abstract][Full Text] [Related]
9. Cellular immunity in myasthenia gravis after thymectomy and corticosteroid therapy. Kawanami S; Mori S; Kamei H; Oita J; Yamasaki H; Okumura M; Shimura H; Shirakusa T Jpn J Med; 1990; 29(2):138-45. PubMed ID: 2232362 [TBL] [Abstract][Full Text] [Related]
10. Influence of adult thymectomy on immunocompetence in patients with myasthenia gravis. Wijermans P; Oosterhuis HJ; Astaldi GC; Schellekens PT; Astaldi A J Immunol; 1980 Apr; 124(4):1977-82. PubMed ID: 7189201 [TBL] [Abstract][Full Text] [Related]
11. Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells. Jakubíková M; Piťha J; Marečková H; Týblová M; Nováková I; Schutzner J J Neurol Sci; 2015 Nov; 358(1-2):101-6. PubMed ID: 26320610 [TBL] [Abstract][Full Text] [Related]
12. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy. Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565 [TBL] [Abstract][Full Text] [Related]
13. Circulating CD4+CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis. Matsui M; Fukuyama H; Akiguchi I; Kameyama M J Neurol; 1989 Sep; 236(6):329-35. PubMed ID: 2571681 [TBL] [Abstract][Full Text] [Related]
14. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Fattorossi A; Battaglia A; Buzzonetti A; Ciaraffa F; Scambia G; Evoli A Immunology; 2005 Sep; 116(1):134-41. PubMed ID: 16108825 [TBL] [Abstract][Full Text] [Related]
15. [Acute systemic lupus erythematosus after thymectomy for myasthenia. Sequential study of lymphocyte subpopulations]. Le Loet X; Pouyol F; Lees O; Ducastelle T; Godin M; Deshayes P Rev Med Interne; 1986 Sep; 7(4):425-32. PubMed ID: 3797875 [TBL] [Abstract][Full Text] [Related]
16. Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy. Sun Y; Qiao J; Lu CZ; Zhao CB; Zhu XM; Xiao BG Clin Immunol; 2004 Sep; 112(3):284-9. PubMed ID: 15308122 [TBL] [Abstract][Full Text] [Related]
17. Immunological studies in thymectomized and non-thymectomized patients with myasthenia gravis. Sørensen SF; Andersen V; Bendtzen K; Fulpius BW; Krarup C; Monnier VM; Permin H; Platz P; Søeberg B; Thomsen M J Clin Lab Immunol; 1978 Nov; 1(3):169-78. PubMed ID: 387958 [TBL] [Abstract][Full Text] [Related]
18. Thymectomy as treatment of autoimmune diseases other than myasthenia gravis. D'Andrea V; Malinovsky L; Ambrogi V; Artico M; Capuano LG; Buccolini F; De Antoni E Thymus; 1993 Feb; 21(1):1-10. PubMed ID: 8480342 [TBL] [Abstract][Full Text] [Related]
19. Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy. Huang YM; Pirskanen R; Giscombe R; Link H; Lefvert AK Scand J Immunol; 2004 Apr; 59(4):408-14. PubMed ID: 15049785 [TBL] [Abstract][Full Text] [Related]
20. Development of systemic lupus erythematosus after thymectomy for myasthenia gravis. Studies of suppressor cell function. Calabrese LH; Bach JF; Currie T; Vidt D; Clough J; Krakauer RS Arch Intern Med; 1981 Feb; 141(2):253-5. PubMed ID: 6450575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]